| Compound Information | |
|---|---|
| ID | 360 |
| TrivialName | Notoginsenoside T1 |
| Type | C17-side chain varied |
| MF | C₃₆H₆₀O₁₀ |
| MolecularWeight | 652.866 |
| IUPACName | 2-[[17-[(E)-4-(3,3-dimethyloxiran-2-yl)-4-hydroxybut-2-en-2-yl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| m/z | NT |
| Retention Time | NT |
| CCS | NT |
| Adducts | NT |
| Isomeric SMILES | O[C@H]1[C@H](O[C@@H]2C3C(C)(C)[C@@H](O)CC[C@]3(C)C4[C@@]([C@@](CCC5/C(C)=C\C(O)C6OC6(C)C)(C)C5[C@H](O)C4)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O |
| Canonical SMILES | CC(=CC(O)C1OC1(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(OC3OC(CO)C(O)C(O)C3O)CC12C |
| Source | PN |
| Functions | Anti-inflammatory, anticancer, & anti-atherosclerotic |
| Year | 2004 |
| References | |
| Structure |
|